Newsroom

Axithra appoints Lars Kongsbak as CEO to lead next phase of growth and series A financing

iProcess Global Research launches AxisOne: the R&D operating system for the world

ENPICOM joins the Pistoia Alliance

Leinco Technologies and CellCarta collaborate to advance proteomics solutions and applications for drug development

Takara Bio and Resistomap deepen collaboration to advance One Health AMR Surveillance with the SmartChip Biosecurity Platform

Medix Biochemica appoints Petra Furu as Chief Executive Officer

Biognosys Group announces collaboration with The Michael J. Fox Foundation to advance Parkinson’s disease research through the development of improved biomarker assays

Enhanced Compliance Inc. (ECI) appoints Khalid Raja as Senior Vice President, Strategic Growth & Advisory

CellCarta and Pillar Biosciences announce multi-year global strategic partnership to expand rapid, decentralized tumor profiling for oncology clinical trials

Plasmidsaurus accelerates RNA-Seq: New EU hub and Genovis partnership adds stability to speed, without the ice

Lonza launches media development lab in Singapore for cell culture media optimization

New global partnership between Sakura Finetek and Hamamatsu Photonics strengthens the digital pathology workflow from slide preparation to imaging

CellCarta secures global exclusivity for Biofidelity's Aspyre® Lung to advance targeted lung cancer testing

Epigenica AB Expands presence in Japan through distribution agreement with PrimeTech

Arctoris Launches Biophysics Centre of Excellence to Bridge the AI-Experimentation Gap in Drug Discovery

University of Colorado grants license to Cirena for RNA-synthesis technology

Epigenica AB launches EpiFinder™ cNUC: The first platform to simultaneously profile multiple histone marks and DNA methylation directly from circulating nucleosomes in plasma and serum

Inceptua Group appoints healthcare industry leader Kurt Hilzinger as chairman of the board

Cirena launches high-purity long RNA to accelerate CRISPR and genome-editing research

Fidēs Imaging launches next-generation imaging core lab

Epigenica launches EpiFinder™ Analysis Service, a fully managed platform for fast and reliable epigenomic insights

Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director

Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to include Morocco and Egypt.

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

Lonza to expand bioscience testing offering with the acquisition of Redberry

EazeBio and UC Santa Cruz announce strategic partnership to advance instrument-free diagnostic platform

Alithea Genomics introduces MERCURIUS™ Spheroid DRUG-seq: extraction-free, RNA-seq for 3D drug screening and toxicology

Lonza expands its TheraPEAK® product portfolio with the addition of AmpliCell® Cytokine range and TheraPEAK® 293-GT® Medium

PromoCell enters the GMP field with custom cell culture media services for cell-based therapy and regenerative medicine

Takara Bio Europe launches Cellartis® MSC EV Wonder™, a defined, xeno-free medium for high-yield EV production

PHC Corporation’s Biomedical Division wins 2025 R&D 100 award for LiCellMo Live Cell Metabolic Pathway Analyzer

EpiCypher launches Fiber-seq, a breakthrough multiomic single-molecule genomics assay

Aptamer Group introduces novel biomarker discovery service

Friends of Cancer Research and MMS collaborate to develop decision frameworks for interim overall survival data in oncology trials

Takara Bio Europe signs distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products

Alithea Genomics announces the launch of MERCURIUS™ FLASH-seq: a plate-based, full-length single cell RNA-seq kit delivering exceptional sensitivity and simplicity

Alithea Genomics launches MERCURIUS™ Total DRUG-seq: a next-generation full-length transcriptome profiling platform for high-throughput compound screening and target validation

Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer

Ceryx Medical secures $15 million to advance groundbreaking heart failure technology

GenNext Technologies and Thermo Fisher Scientific collaborate to simplify structural biology for faster biotherapeutic development

EpiCypher launches novel, affordable DNA methylation sequencing assays to accelerate drug discovery

Indivumed celebrates milestone of its patient-centric R&D platform: Numerous novel cancer targets discovered for first-in-class therapeutics

ONTOFORCE’s DISQOVER chosen by The Michael J. Fox Foundation to enhance the integration and access of Parkinson’s disease research data

PHC launches next-generation CO2 incubator combining advanced antimicrobial technology with eco-conscious design

Tillotts Pharma AG celebrates 15 years as an integral part of the Japanese Zeria Group

JuliaHub doubles investment in advanced pharmaceutical modeling platform

Synexa Life Sciences achieves highest level My Green Lab certification, reinforcing commitment to lab sustainability

UK Biocentre selects the Azenta Life Sciences BioArc Ultra automated storage system to advance research excellence

Medix Biochemica expands its offering of critical IVD raw materials to premium blockers and stabilizers by acquiring CANDOR Bioscience

Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials

PrecisionLife appoints Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare

Leica Biosystems and Indica Labs announce significant strategic investment and creation of digital pathology platform

ENEA-Tech Biomedical Foundation invests €6m in BetaGlue® Therapeutics brings 2024 funding round total to €24m

The Institute of Tissue Medicine of the University of Bern chooses Indica Labs’ HALO AP®

PHC Corporation of North America to unveil LiCellGrow prototype at Advanced Therapies Week

Ceryx Medical initiates first-in-human study of the Cysoni™ RSA Pacemaker

Supreme Group acquires Amendola, an award-winning healthcare, health tech and life sciences PR and marketing agency

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market

Duke Street Bio announces first patient dosed in Phase I trial with DSB2455, a next deneration PARP1 selective inhibitor for the treatment of solid tumours

Tillotts Pharma partners with Pioneer for the marketing and distribution of Tillotts` product Asacol® in the People’s Republic of China

Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses

New AffiniPure® Rabbit Anti-GFP antibodies from Jackson ImmunoResearch

Azenta obtains regulatory approval for clinical long-read Whole Genome Sequencing test

MMS named a finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

Takara Bio Europe expands existing Gothenburg site to offer custom enzyme manufacturing

ProPharma receives 2024 CPHI Regulatory and Compliance Award

Exothera announced the appointment of Cedric Volanti as CEO

ABITEC unveils comprehensive custom lipid synthesis capabilities for LNP therapeutics

Synexa Life Sciences expands bioanalysis capabilities with the acquisition of CRO Alderley Analytical

ProPharma names Dawn Sherman Chief Executive Officer

CRDSA announces publication of Standards for Clinical Trial Data Reuse

Takara Bio Europe unveils new large-scale NGS profiling system and chemistries

Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial

PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study

DevCo has completed a strategic capital raise for its long-term investment in Medix Biochemica

GenNext and Agilent unveil groundbreaking technology integration to accelerate high-value decision making in biopharmaceutical research

Medical University of Graz selects the HALO AP® digital pathology platform to deliver comprehensive diagnostics

Indica Labs and Paige forge strategic partnership to expand integrated AI for anatomic pathology labs

Supreme Group acquires BioStrata, an award-winning UK-based life science marketing and public relations agency

International consortium to revolutionize viral vector manufacturing

Qubit Pharmaceuticals nominated for "Best start-up 2024" award by Prix Galien USA

Champalimaud Foundation adopts Lonza’s MODA-ES® Platform to streamline cell therapy manufacturing

Two new scoping reviews of heated tobacco science by Imperial Brands further substantiate the category's tobacco harm reduction potential

Indica Labs announces launch of AI-powered Macrodissection Suite to advance molecular pathology workflows

Trial approval for new pacemaker aiming to boost recovery in heart failure

SSI Strategy and Metalmind partner for enterprise AI solutions

‘Biolyst Scientific’ announced as new brand name to encompass EMS and Azer, will deepen offerings to clinical and research lab customers

Dexwell showcases coastal protection innovation with SeaPULSE platform, providing hands-on experience for Rady School of Business interns

Avallano releases ProtocolCopilot: Powering clinical research with AI-driven protocol assistance

Surfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening

Synexa Life Sciences enrols in My Green Lab Certification Program

Medix Biochemica announces that Lonnie Shoff, former President of the Clinical Diagnostics Division at Thermo Fisher Scientific has been appointed its Board of Directors

Indica Labs expands availability of HALO digital pathology solutions in Asia Pacific Region including CE-IVDR marked HALO AP® platform

Avallano strengthens leadership with new chief strategy officer to drive AI-powered clinical research innovation

Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease

Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage

City University of New York partners with Genestack to enhance AI readiness of life science data in the Bioconductor Program

Novel Concepts Medical announces over 99% decrease in breakthrough lab results of lung and breast cancer

Indica Labs announces AI-powered HALO® software release for digital pathology research in life sciences

Sakura Finetek Europe B.V. advances its laboratory automation with the Tissue-Tek xPrint® LP Laser Cassette Printer

Indica Labs receives FDA clearance for HALO AP Dx digital pathology platform for use with Hamamatsu Images acquired with the NanoZoomer® S360MD Slide scanner

Inceptua Group expands Early Access Program to Latin America

Icosagen and Lead Discovery Center announce collaboration to discover novel monoclonal antibodies

Launch of a mutant RNA T7 polymerase with highly reduced double-stranded RNA formation

Indica Labs receives first FDA clearance for HALO AP Dx digital pathology platform

PrecisionLife and Metrodora Institute launch clinical trials to accelerate the diagnosis and treatment of ME/CFS and Long Covid patients

Gentronix recognised with King’s award after record international growth

BBI and BioAgilytix partner to streamline and simplify bioanalytical testing

Revolutionizing patient care: ProPharma and PBL launch innovative cell & gene therapy manufacturing device

Novel Concepts Medical announces a breakthrough colon cancer study

Sakura Finetek Europe BV welcomes Mr Jaap Stuut as its President and General Manager

BBI Solutions announces successful closing of acquisition of IBEX Technologies

Veramed appoints Karen Curran as Chief Strategy Officer

Synexa Life Sciences expands biomarker discovery capabilities with the addition of Olink® target platform

The University of Edinburgh acknowledges Pelago patent and use of CETSA® process

Biotium expands selection of novel Nuclear Stains for enhanced multiplexing flexibility for microscopy and flow cytometry applications

ENPICOM partners with Erasmus University Medical Center in groundbreaking effort to discover nanobodies against cancer

Horizon CME announces first annual summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)

PrecisionLife and Metrodora Institute partner to accelerate the diagnosis and treatment of long COVID, ME/CFS, and other chronic conditions

Showcase on lab automation instruments and consumables on display at SLAS2024 International Conference and Exhibition

Azenta launches the BioArc Ultra™, a breakthrough, automated solution for efficient, eco-friendly ultracold sample management

Quantify Research opens new office in Finland

Effortless measurement of all four NADs and glutathione for laboratories

Inceptua Group and Cycle Pharmaceuticals partner for a Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU).

Argenta combines legacy brands to further advance animal health: One Brand, One Vision

PrecisionLife project awarded Innovate UK Grant to improve diagnosis and treatment of ME/CFS and Long Covid

Thermo Fisher Scientific signs long-term, exclusive U.S. distributor agreement with Aesku.Group for IFA testing kits & instruments

TransCure bioServices strengthens team with C-suite hire and boosts North American preclinical opportunities

ENPICOM and Carterra advance antibody screening by integrating biophysical characterization and repertoire sequencing analysis

Revolutionary danish cancer app set for nationwide launch: A milestone in digital healthcare

Biotium launches new line of extensively validated primary antibody conjugates for flow cytometry

Exothera’s CTO Patrick Thiaville nominated as a member of Alliance for mRNA Medicines Board

PrecisionLife announces new appointments to launch diagnostics and healthcare strategy

Medix Biochemica expands its infectious diseases antibody offering through the acquisition of ViroStat

NSF TraQtion powers Novozymes’ raw material management in industry first

SPT Labtech launches firefly® for LDT to streamline liquid handling in NGS-based Laboratory Developed Tests

Lonza’s rapid PyroCell® Monocyte Activation Test Systems make rabbit-free pyrogen testing faster, easier, and more efficient

Biotium introduces new highly-selective stains for both gram-positive and gram-negative bacteria

Veramed expands its global footprint by acquiring Data Management, Biostatistics and Medical Writing services company Clinical Trial Data Services (CTDS)

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

Alder Therapeutics set to redefine cell therapy development

New hot start isothermal mixes boost sensitivity, specificity, and speed of DNA target detection

Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor

HERMES PHARMA announces €25 million investment to bolster capacity

Announcing Kivo GO: An intuitive DMS to accelerate speed-to-market for life sciences

SMi Systems secures UK patent for breakthrough single molecule imaging capabilities

Launch of high-quality (pre-clinical) enzymes suitable for pre-clinical and process development in mRNA vaccine and therapeutics

iotaSciences presents first encouraging data for use of new isoPick™ Single-Cell Picker for mass spectrometric analysis of single cells

Lonza upgrades MODA-ES® module for enhanced electronic batch record execution

iotaSciences and Quantum Design China enter into distribution agreement

GenNext & SCIEX to Co-Market an Advanced High Order Structure Analysis (HOS) Workflow for Biopharmaceutical Research

GenNext unveils the world’s first fully automated protein footprinting system at the California Separation Science Society Meeting

NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

SSI Strategy and NDA Group combine to form best-in-class global life sciences consultancy

ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium

Lonza launches Nebula® Absorbance Reader for streamlined endotoxin and pyrogen testing

iotaSciences appoints Dr. Michael Lutz as new Chief Executive Officer

Titian Software enters a 3-year agreement with leading life science company

TransCure bioServices expands reach into APAC with Preclina Inc partnership

Tillotts Pharma and TVM Capital Life Science announce formation of Mage Biologics to develop innovative oral antibody therapy for ulcerative colitis

PromoCell Launches PromoExQ MSC Growth Medium XF for GMP Compliant Long-term Expansion of Mesenchymal Stem Cells

Adlib + Generis partnership: A “Game Changer” for regulated companies

PrecisionLife identifies first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases

Lonza launches TheraPRO® CHO Media System to improve productivity and quality in therapeutic protein manufacture

Cytel acquires French group stève consultants to further expand value evidence and real-world analytics capabilities

VitaDAO launches VITA-FAST tokens, revolutionizing governance in longevity research

ENPICOM secures extended financing from BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital

PrecisionLife licenses University of Oxford data to discover personalised treatments for endometriosis patients

Meissa Vaccines enters into CGMP manufacturing agreement for pediatric RSV vaccine candidate for phase 2 clinical trials

Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET™ technology

Biotium introduces novel antibody labeling kits for rapid and efficient labeling of IgM antibodies

PrecisionLife announces strategic CNS drug development collaboration with Nanopharmaceutics

AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio

SMi discloses £6 million seed funding round, bolsters team with new C-suite hire

Indica Labs launches comprehensive management service for HALO® software in AWS cloud-hosted environments

New CapnoPen® CP-001k receives CE certification (MDR)

Synexa Life Sciences joins CEPI in advancing global epidemic preparedness and response

The only LIMS platform fully developed on FAIR data principles launches at Bio-IT World 2023

Oncodesign Services and Veritas In Silico enter into business cooperation on developing mRNA-targeted small molecule drugs

GenNext® Technologies announces partnership with Emery Pharma on full-solution biopharmaceutical protein footprinting services

Lonza launches TheraPEAK® T-VIVO® cell culture medium to accelerate cell therapy development

Neutec Group introduces the oCelloscope automated microbial live-cell imaging technology, by Biosense Solutions

Thermo Fisher Scientific expands ImmunoCAP™ test availability across U.S.

Top 5 ‘not to be missed’ highlights at this year’s Genomics and Precision Medicine Expo

Exothera Nucleic Acids strengthens team with industry expert

Exothera announces a strategic partnership with Quantoom Biosciences and launches a new business unit for the development and production of RNA

Indica Labs and Lunit announce a strategic alliance for seamless integrated digital pathology AI workflows

New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”

Molecular and digital pathology innovators Xyall and Indica Labs forge global collaboration to transform precision oncology workflows

Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...

June 16, 2026

New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen...

READ MORE

Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer

June 16, 2026

Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience...

READ MORE

Alithea Genomics and Revvity announce distribution agreement to expand access to MERCURIUS™ DRUG-seq...

June 8, 2026

Alithea Genomics, a pioneering biotech company specializing in scalable RNA sequencing solutions, today announced a new agreement with Revvity Inc. to...

READ MORE